Glutathione protects human airway proteins and epithelial cells from isocyanates

Clinical and Experimental Allergy

Volumn 35, Issue 3, 2005, Pages 352-357

  Wisnewski, Adam V ^a   Liu, Q ^a   Liu, J ^a   Redlich, C A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway epithelial cell; Albumin; Conjugation; Glutathione; GSH; GSSG; HDI; Hexamethylene diisocyanate; Oxidized; Reduced; Toxicity

Indexed keywords

ALBUMIN; GLUTATHIONE; HEXAMETHYLENE DIISOCYANATE; ISOCYANATE;

AIRWAY; ALLERGY; ARTICLE; ASTHMA; CELL PROTECTION; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; OCCUPATIONAL EXPOSURE; OXIDATION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SENSITIZATION;

AIR POLLUTANTS, OCCUPATIONAL; ASTHMA; CELL LINE; CYANATES; EPITHELIAL CELLS; GLUTATHIONE; HUMANS; HYPERSENSITIVITY; OCCUPATIONAL DISEASES; RESPIRATORY MUCOSA;

EID: 17144422061     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02185.x     Document Type: Article

References (49)

1. Brugsch HG, Elkins HB. Toluene di-isocyanate (TDI) toxicity. N Engl J Med 1963; 268:353-7.
2. Liu Q, Wisnewski AV. Recent developments in diisocyanate asthma. Ann Allergy Asthma Immunol 2003; 90:35-41.
3. Swensson A, Holmquist CE, Lundgren KD. Injury to the respiratory tract by isocyanates used in making lacquers. Br J Ind Med 1955; 12:50-3.
4. Pepys J, Pickering CA, Breslin AB, Terry DJ. Asthma due to inhaled chemical agents, tolylene di-isocyanate. Clin Allergy 1972; 2:225-36.
5. Scheel LD, Killens R, Josephson A. Immunochemical Aspects of Toluene Diisocyanate (TDI) Toxicity. Am Ind Hyg Assoc J 1964; 25:179-84.
6. Avery SB, Stetson DM, Pan PM, Mathews KP. Immunological investigation of individuals with toluene diisocyanate asthma. Clin Exp Immunol 1969; 4:585-96.
7. Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2002; 2:213-24.
8. Wisnewski AV, Redlich CA. Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol 2001; 1:169-75.
9. Tse CS, Pesce AJ. Chemical characterization of isocyanate-protein conjugates. Toxicol Appl Pharmacol 1979; 51:39-46.
10. Wisnewski AV, Srivastava R, Herick C et al. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 2000; 162:2330-6.
11. Day BW, Jin R, Basalyga DM, Kramarik JA, Karol MH. Formation, solvolysis, and transcarbamoylation reactions of bis(S-glutathionyl) adducts of 2,4- and 2,6-diisocyanatotoluene. Chem Res Toxicol 1997; 10:424-31.
12. Lange RW, Day BW, Lemus R, Tyurin VA, Kagan VE, Karol MH. Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene. Chem Res Toxicol 1999; 12:931-6.
13. Mapp CE, Fryer AA, De Marzo N et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol 2002; 109:867-72.
14. Piirila P, Wikman H, Luukkonen R et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001; 11:437-45.
15. Karol MH. Bonding and transfer: do epithelial conjugates have a role in chemical asthma? Clin Exp Allergy 2001; 31:357-60.
16. Lantz RC, Lemus R, Lange RW, Karol MH. Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate. Toxicol Sci 2001; 60:348-55.
17. Meister A. Glutathione and the gamma-glutyamyl cycle. In: Arias IM, Jakoby WB, eds. Glutathione: Metabolism and Function. New York: Raven Press, 1976; 35-41.
18. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152-7.
19. van der Vliet A, O'Neill CA, Cross CE et al. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. Am J Physiol 1999; 276:L289-96.
20. Roum JH, Borok Z, McElvaney NG et al. Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol 1999; 87:438-43.
21. Rahman I, van Schadewijk AA, Hiemstra PS et al. Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radical Biol Med 2000; 28:920-5.
22. Rahman I, Swarska E, Henry M, Stolk J, MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000; 55:189-93.
23. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16:534-54.
24. Smith LJ, Houston M, Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis 1993; 147:1461-4.
25. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148:1174-8.
26. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100:1397-403.
27. Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002; 110:349-56.
28. Wisnewski AV, Cartier A, Liu Q et al. Isocyanate vapor-induced antigenicity of albumin. J Allergy Clin Immunol 2004; 113:1178-84.
29. Vandenplas O, Delwiche JP, Staquet P et al. Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects. Eur Respir J 1999; 13:1144-50.
30. Wisnewski AV, Lemus R, Karol MH, Redlich CA. Isocyanate-conjugated human lung epithelial cell proteins: a link between exposure and asthma? J Allergy Clin Immunol 1999; 104:341-7.
31. Wisnewski AV, Liu Q, Miller JJ, Magoski N, Redlich CA. Effects of hexamethylene diisocyanate exposure on human airway epithelial cells: in vitro cellular and molecular studies. Environ Health Perspect 2002; 110:901-7.
32. Coligan J, Kruisbeck A, Marguiles D, Sevacch E, Stober W, eds. Current Protocols in Immunology. West Sussex: Wiley and Sons, Inc., 1998.
33. Kang YJ, Enger MD. Glutathione content and growth in A549 human lung carcinoma cells. Exp Cell Res 1990; 187:177-9.
34. Rahman I, Mulier B, Gilmour PS et al. Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-kappa B. Biochem Pharmacol 2001; 62:787-94.
35. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27:502-22.
36. Karol MH, Hauth BA. Use of hexyl isocyanate antigen to detect antibodies to hexamethylene diisocyanate (HDI) in sensitized guinea pigs and in a sensitized worker. Fund Appl Toxicol 1982; 2:108-13.
37. Pauluhn J. Inhalation toxicity of 1,6-hexamethylene diisocyanate homopolymer (HDI-IC) aerosol: results of single inhalation exposure studies. Toxicol Sci 2000; 58:173-81.
38. Pauluhn J. Acute inhalation toxicity of polymeric diphenyl-methane 4,4′-diisocyanate in rats: time course of changes in bronchoalveolar lavage. Arch Toxicol 2000; 74:257-69.
39. Rahman I. Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells. Biochem Pharmacol 2000; 60:1041-9.
40. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radical Biol Med 2000; 28:1405-20.
41. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, MacHino T. Horie T. Intracellular glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation and RANTES production by human bronchial epithelial cells. Clin Exp Allergy 2001; 31:144-51.
42. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radical Biol Med 2000; 28:463-99.
43. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA 1998; 95:3071-6.
44. Zhu BZ, Carr AC, Frei B. Pyrrolidine dithiocarbamate is a potent antioxidant against hypochlorous acid-induced protein damage. FEBS Lett 2002; 532:80-4.
45. Reisser M, Schmidt BF, Brown WE. Synthesis, characterization, and solvolysis of mono- and bis-S-(glutathionyl) adducts of methylene-bis- (phenylisocyanate) (MD1). Chem Res Toxicol 2002; 15:1235-41.
46. Borok Z, Buhl R, Grimes GJ et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338:215-6.
47. Buhl R, Vogelmeier C, Critenden M et al. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci USA 1990; 87:4063-7.
48. Holroyd KJ, Buhl R, Borok Z et al. Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax 1993; 48:985-9.
49. Marrades RM, Roca J, Barbera JA, de Jover L, MacNee W, Rodriguez-Roisin R. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med 1997; 156:425-30.